Julie Chao - Publications

Affiliations: 
Medical University of South Carolina, Charleston, SC, United States 
Area:
Biochemistry

163 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Chao J, Guo Y, Chao L. Protective Role of Endogenous Kallistatin in Vascular Injury and Senescence by Inhibiting Oxidative Stress and Inflammation. Oxidative Medicine and Cellular Longevity. 2018: 4138560. PMID 30622668 DOI: 10.1155/2018/4138560  0.393
2018 Yao Y, Li B, Liu C, Fu C, Li P, Guo Y, Ma G, Liu N, Chao L, Chao J. Reduced Plasma Kallistatin Is Associated With the Severity of Coronary Artery Disease, and Kallistatin Treatment Attenuates Atherosclerotic Plaque Formation in Mice. Journal of the American Heart Association. 7: e009562. PMID 30554563 DOI: 10.1161/Jaha.118.009562  0.353
2018 Guo Y, Chao L, Chao J. Kallistatin attenuates endothelial senescence by modulating Let-7g-mediated miR-34a-SIRT1-eNOS pathway. Journal of Cellular and Molecular Medicine. PMID 29992759 DOI: 10.1111/Jcmm.13734  0.355
2017 Chao J, Guo Y, Li P, Chao L. Opposing Effects of Oxygen Regulation on Kallistatin Expression: Kallistatin as a Novel Mediator of Oxygen-Induced HIF-1-eNOS-NO Pathway. Oxidative Medicine and Cellular Longevity. 2017: 5262958. PMID 29387292 DOI: 10.1155/2017/5262958  0.36
2017 Chao J, Guo Y, Li P, Chao L. Role of Kallistatin Treatment in Aging and Cancer by Modulating miR-34a and miR-21 Expression. Oxidative Medicine and Cellular Longevity. 2017: 5025610. PMID 28744338 DOI: 10.1155/2017/5025610  0.316
2017 Chao J, Li P, Chao L. Kallistatin: double-edged role in angiogenesis, apoptosis and oxidative stress. Biological Chemistry. PMID 28742513 DOI: 10.1515/Hsz-2017-0180  0.386
2017 Guo Y, Li P, Gao L, Zhang J, Yang Z, Bledsoe G, Chang E, Chao L, Chao J. Kallistatin reduces vascular senescence and aging by regulating microRNA-34a-SIRT1 pathway. Aging Cell. PMID 28544111 DOI: 10.1111/Acel.12615  0.734
2017 Chao J, Li P, Chao L. Kallistatin suppresses cancer development by multi-factorial actions. Critical Reviews in Oncology/Hematology. 113: 71-78. PMID 28427524 DOI: 10.1016/J.Critrevonc.2017.03.011  0.346
2016 Chao J, Bledsoe G, Chao L. Protective Role of Kallistatin in Vascular and Organ Injury. Hypertension. PMID 27432868 DOI: 10.1161/Hypertensionaha.116.07861  0.777
2016 Zhang Q, Lee CS, Chao J, Chen CL, Zhang T, Sharma U, Zhang A, Liu J, Rezaei K, Pepple KL, Munsen R, Kinyoun J, Johnstone M, Van Gelder RN, Wang RK. Wide-field optical coherence tomography based microangiography for retinal imaging. Scientific Reports. 6: 22017. PMID 26912261 DOI: 10.1038/Srep22017  0.569
2016 Li P, Guo Y, Bledsoe G, Yang Z, Chao L, Chao J. Kallistatin Induces Breast Cancer Cell Apoptosis and Autophagy by Modulating Wnt Signaling and microRNA Synthesis. Experimental Cell Research. PMID 26790955 DOI: 10.1016/J.Yexcr.2016.01.004  0.724
2015 Wang Y, Chen CL, Pan QZ, Wu YY, Zhao JJ, Jiang SS, Chao J, Zhang XF, Zhang HX, Zhou ZQ, Tang Y, Huang XQ, Zhang JH, Xia JC. Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma. Oncotarget. PMID 26575170 DOI: 10.18632/oncotarget.6319  0.588
2015 Zhang XF, Chao J, Pan QZ, Pan K, Weng DS, Wang QJ, Zhao JJ, He J, Liu Q, Jiang SS, Chen CL, Zhang HX, Xia JC. Overexpression of WWP1 Promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma. Oncotarget. PMID 26506518 DOI: 10.18632/oncotarget.5712  0.592
2015 Zhu T, Yao Q, Hu X, Chen C, Yao H, Chao J. The Role of MCPIP1 in Ischemia/Reperfusion Injury-Induced HUVEC Migration and Apoptosis. Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 37: 577-591. PMID 26329288 DOI: 10.1159/000430378  0.642
2015 Lin WC, Chen CW, Huang YW, Chao L, Chao J, Lin YS, Lin CF. Kallistatin protects against sepsis-related acute lung injury via inhibiting inflammation and apoptosis. Scientific Reports. 5: 12463. PMID 26198099 DOI: 10.1038/Srep12463  0.681
2015 Guo Y, Li P, Bledsoe G, Yang ZR, Chao L, Chao J. Kallistatin inhibits TGF-β-induced endothelial-mesenchymal transition by differential regulation of microRNA-21 and eNOS expression. Experimental Cell Research. 337: 103-10. PMID 26156753 DOI: 10.1016/J.Yexcr.2015.06.021  0.74
2015 Li P, Guo Y, Bledsoe G, Yang ZR, Fan H, Chao L, Chao J. Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsis. Critical Care (London, England). 19: 200. PMID 25930108 DOI: 10.1186/S13054-015-0919-4  0.72
2015 Hsieh YH, Liu KK, Sulake RS, Chao JI, Chen C. Microwave-assisted efficient conjugation of nanodiamond and paclitaxel. Bioorganic & Medicinal Chemistry Letters. 25: 2074-7. PMID 25890802 DOI: 10.1016/j.bmcl.2015.03.089  0.57
2015 Cheng WC, Chung IF, Tsai CF, Huang TS, Chen CY, Wang SC, Chang TY, Sun HJ, Chao JY, Cheng CC, Wu CW, Wang HW. YM500v2: a small RNA sequencing (smRNA-seq) database for human cancer miRNome research. Nucleic Acids Research. 43: D862-7. PMID 25398902 DOI: 10.1093/Nar/Gku1156  0.576
2014 Yin KH, Hsieh YH, Sulake RS, Wang SP, Chao JI, Chen C. Optimization of gefitinib analogues with potent anticancer activity. Bioorganic & Medicinal Chemistry Letters. 24: 5247-50. PMID 25305687 DOI: 10.1016/j.bmcl.2014.09.056  0.591
2014 Chao J, Bledsoe G, Chao L. Kallikrein-kinin in stem cell therapy. World Journal of Stem Cells. 6: 448-57. PMID 25258666 DOI: 10.4252/Wjsc.V6.I4.448  0.755
2014 Gao L, Li P, Zhang J, Hagiwara M, Shen B, Bledsoe G, Chang E, Chao L, Chao J. Novel role of kallistatin in vascular repair by promoting mobility, viability, and function of endothelial progenitor cells. Journal of the American Heart Association. 3: e001194. PMID 25237049 DOI: 10.1161/Jaha.114.001194  0.739
2014 Chao J, Bledsoe G, Chao L. Tissue kallikrein-kinin therapy in hypertension and organ damage. Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progrã¨S Des Recherches Pharmaceutiques. 69: 37-57. PMID 25130039 DOI: 10.1007/978-3-319-06683-7_3  0.766
2014 Li P, Bledsoe G, Yang ZR, Fan H, Chao L, Chao J. Human kallistatin administration reduces organ injury and improves survival in a mouse model of polymicrobial sepsis. Immunology. 142: 216-26. PMID 24467264 DOI: 10.1111/Imm.12242  0.769
2013 Yang CR, Liao WS, Wu YH, Murugan K, Chen C, Chao JI. CR108, a novel vitamin K3 derivative induces apoptosis and breast tumor inhibition by reactive oxygen species and mitochondrial dysfunction. Toxicology and Applied Pharmacology. 273: 611-22. PMID 24128853 DOI: 10.1016/j.taap.2013.10.007  0.615
2013 Gao L, Bledsoe G, Yin H, Shen B, Chao L, Chao J. Tissue kallikrein-modified mesenchymal stem cells provide enhanced protection against ischemic cardiac injury after myocardial infarction. Circulation Journal : Official Journal of the Japanese Circulation Society. 77: 2134-44. PMID 23697984 DOI: 10.1253/Circj.Cj-12-1585  0.717
2013 Zhang J, Yang Z, Li P, Bledsoe G, Chao L, Chao J. Kallistatin antagonizes Wnt/β-catenin signaling and cancer cell motility via binding to low-density lipoprotein receptor-related protein 6. Molecular and Cellular Biochemistry. 379: 295-301. PMID 23666756 DOI: 10.1007/S11010-013-1654-2  0.732
2013 Yao Y, Sheng Z, Li Y, Fu C, Ma G, Liu N, Chao J, Chao L. Tissue kallikrein-modified human endothelial progenitor cell implantation improves cardiac function via enhanced activation of akt and increased angiogenesis. Laboratory Investigation; a Journal of Technical Methods and Pathology. 93: 577-91. PMID 23508045 DOI: 10.1038/Labinvest.2013.48  0.37
2013 Lin WC, Lu SL, Lin CF, Chen CW, Chao L, Chao J, Lin YS. Plasma kallistatin levels in patients with severe community-acquired pneumonia. Critical Care (London, England). 17: R27. PMID 23394256 DOI: 10.1186/Cc12507  0.626
2012 Liu Y, Bledsoe G, Hagiwara M, Shen B, Chao L, Chao J. Depletion of endogenous kallistatin exacerbates renal and cardiovascular oxidative stress, inflammation, and organ remodeling. American Journal of Physiology. Renal Physiology. 303: F1230-8. PMID 22811485 DOI: 10.1152/Ajprenal.00257.2012  0.778
2012 Patel AB, Chao J, Palmer LG. Tissue kallikrein activation of the epithelial Na channel. American Journal of Physiology. Renal Physiology. 303: F540-50. PMID 22622459 DOI: 10.1152/Ajprenal.00133.2012  0.359
2012 Tseng HH, Chuah QY, Yang PM, Chen CT, Chao JC, Lin MD, Chiu SJ. Securin enhances the anti-cancer effects of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075) in human colorectal cancer cells. Plos One. 7: e36006. PMID 22563433 DOI: 10.1371/journal.pone.0036006  0.635
2012 Cheng CW, Wang HW, Chang CW, Chu HW, Chen CY, Yu JC, Chao JI, Liu HF, Ding SL, Shen CY. MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer. Breast Cancer Research and Treatment. 134: 1081-93. PMID 22476851 DOI: 10.1007/s10549-012-2034-4  0.599
2012 Yao Y, Sheng Z, Li Y, Yan F, Fu C, Li Y, Ma G, Liu N, Chao J, Chao L. Tissue kallikrein promotes cardiac neovascularization by enhancing endothelial progenitor cell functional capacity. Human Gene Therapy. 23: 859-70. PMID 22435954 DOI: 10.1089/Hum.2011.123  0.423
2012 Leung TK, Chen CH, Lai CH, Lee CM, Chen CC, Yang JC, Chen KC, Chao JS. Bone and joint protection ability of ceramic material with biological effects. The Chinese Journal of Physiology. 55: 47-54. PMID 22242954 DOI: 10.4077/CJP.2012.AMM113  0.627
2012 Leung TK, Huang PJ, Sun LM, Chu JS, Chen CS, Lee CM, Wu CH, Chao JS. Silicone breast implant with intracapsular rupture coexisting with locally advanced carcinoma. The Breast Journal. 18: 76-7. PMID 22060279 DOI: 10.1111/j.1524-4741.2011.01187.x  0.57
2011 Tsai CC, Liu HF, Hsu KC, Yang JM, Chen C, Liu KK, Hsu TS, Chao JI. 7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel ROCK inhibitor blocks cytoskeleton function and cell migration. Biochemical Pharmacology. 81: 856-65. PMID 21276421 DOI: 10.1016/j.bcp.2011.01.009  0.61
2010 Leung TK, Huang PJ, Lee CM, Chen CS, Wu CH, Chao JS. Can breast magnetic resonance imaging demonstrate characteristic findings of preoperative ductal carcinoma in situ in Taiwanese women? Asian Journal of Surgery / Asian Surgical Association. 33: 143-9. PMID 21163412 DOI: 10.1016/S1015-9584(10)60024-3  0.564
2010 Shen B, Gao L, Hsu YT, Bledsoe G, Hagiwara M, Chao L, Chao J. Kallistatin attenuates endothelial apoptosis through inhibition of oxidative stress and activation of Akt-eNOS signaling. American Journal of Physiology. Heart and Circulatory Physiology. 299: H1419-27. PMID 20729399 DOI: 10.1152/Ajpheart.00591.2010  0.766
2010 Liu KK, Zheng WW, Wang CC, Chiu YC, Cheng CL, Lo YS, Chen C, Chao JI. Covalent linkage of nanodiamond-paclitaxel for drug delivery and cancer therapy. Nanotechnology. 21: 315106. PMID 20634575 DOI: 10.1088/0957-4484/21/31/315106  0.614
2010 Yin H, Gao L, Shen B, Chao L, Chao J. Kallistatin inhibits vascular inflammation by antagonizing tumor necrosis factor-alpha-induced nuclear factor kappaB activation. Hypertension. 56: 260-7. PMID 20566960 DOI: 10.1161/Hypertensionaha.110.152330  0.368
2010 Gao L, Smith RS, Chen LM, Chai KX, Chao L, Chao J. Tissue kallikrein promotes prostate cancer cell migration and invasion via a protease-activated receptor-1-dependent signaling pathway. Biological Chemistry. 391: 803-12. PMID 20482314 DOI: 10.1515/Bc.2010.084  0.336
2010 Chao J, Shen B, Gao L, Xia CF, Bledsoe G, Chao L. Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing. Biological Chemistry. 391: 345-55. PMID 20180644 DOI: 10.1515/Bc.2010.042  0.766
2010 Liu Y, Bledsoe G, Hagiwara M, Yang ZR, Shen B, Chao L, Chao J. Blockade of endogenous tissue kallikrein aggravates renal injury by enhancing oxidative stress and inhibiting matrix degradation. American Journal of Physiology. Renal Physiology. 298: F1033-40. PMID 20089675 DOI: 10.1152/Ajprenal.00518.2009  0.779
2010 Shen B, Chao L, Chao J. Pivotal role of JNK-dependent FOXO1 activation in downregulation of kallistatin expression by oxidative stress. American Journal of Physiology. Heart and Circulatory Physiology. 298: H1048-54. PMID 20081110 DOI: 10.1152/Ajpheart.00826.2009  0.365
2010 Gao L, Chao L, Chao J. A novel signaling pathway of tissue kallikrein in promoting keratinocyte migration: activation of proteinase-activated receptor 1 and epidermal growth factor receptor. Experimental Cell Research. 316: 376-89. PMID 19879874 DOI: 10.1016/J.Yexcr.2009.10.022  0.351
2009 Shen B, Smith RS, Hsu YT, Chao L, Chao J. Kruppel-like factor 4 is a novel mediator of Kallistatin in inhibiting endothelial inflammation via increased endothelial nitric-oxide synthase expression. The Journal of Biological Chemistry. 284: 35471-8. PMID 19858207 DOI: 10.1074/Jbc.M109.046813  0.371
2009 Smith RS, Gao L, Bledsoe G, Chao L, Chao J. Intermedin is a new angiogenic growth factor. American Journal of Physiology. Heart and Circulatory Physiology. 297: H1040-7. PMID 19592612 DOI: 10.1152/Ajpheart.00404.2009  0.776
2008 Hagiwara M, Bledsoe G, Yang ZR, Smith RS, Chao L, Chao J. Intermedin ameliorates vascular and renal injury by inhibition of oxidative stress. American Journal of Physiology. Renal Physiology. 295: F1735-43. PMID 18829738 DOI: 10.1152/Ajprenal.90427.2008  0.792
2008 Chao J, Yin H, Gao L, Hagiwara M, Shen B, Yang ZR, Chao L. Tissue kallikrein elicits cardioprotection by direct kinin b2 receptor activation independent of kinin formation. Hypertension. 52: 715-20. PMID 18768400 DOI: 10.1161/Hypertensionaha.108.114587  0.391
2008 Gao L, Yin H, S Smith R, Chao L, Chao J. Role of kallistatin in prevention of cardiac remodeling after chronic myocardial infarction. Laboratory Investigation; a Journal of Technical Methods and Pathology. 88: 1157-66. PMID 18762777 DOI: 10.1038/Labinvest.2008.85  0.366
2008 Yao YY, Yin H, Shen B, Smith RS, Liu Y, Gao L, Chao L, Chao J. Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3beta pathway. Cardiovascular Research. 80: 354-64. PMID 18689794 DOI: 10.1093/Cvr/Cvn223  0.349
2008 Smith RS, Gao L, Chao L, Chao J. Tissue kallikrein and kinin infusion promotes neovascularization in limb ischemia. Biological Chemistry. 389: 725-30. PMID 18627294 DOI: 10.1515/Bc.2008.084  0.41
2008 Hagiwara M, Shen B, Chao L, Chao J. Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation. Human Gene Therapy. 19: 807-19. PMID 18554097 DOI: 10.1089/Hum.2008.016  0.442
2008 Shen B, Hagiwara M, Yao YY, Chao L, Chao J. Salutary effect of kallistatin in salt-induced renal injury, inflammation, and fibrosis via antioxidative stress. Hypertension. 51: 1358-65. PMID 18391098 DOI: 10.1161/Hypertensionaha.107.108514  0.442
2008 Bledsoe G, Shen B, Yao YY, Hagiwara M, Mizell B, Teuton M, Grass D, Chao L, Chao J. Role of tissue kallikrein in prevention and recovery of gentamicin-induced renal injury. Toxicological Sciences : An Official Journal of the Society of Toxicology. 102: 433-43. PMID 18227104 DOI: 10.1093/Toxsci/Kfn008  0.78
2008 Hsu TS, Chen C, Lee PT, Chiu SJ, Liu HF, Tsai CC, Chao JI. 7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway. Cancer Chemotherapy and Pharmacology. 62: 799-808. PMID 18193228 DOI: 10.1007/s00280-007-0667-5  0.603
2008 Yin H, Chao L, Chao J. Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusion. Life Sciences. 82: 156-65. PMID 18068196 DOI: 10.1016/J.Lfs.2007.10.021  0.379
2007 Yao YY, Yin H, Shen B, Chao L, Chao J. Tissue kallikrein and kinin infusion rescues failing myocardium after myocardial infarction. Journal of Cardiac Failure. 13: 588-96. PMID 17826650 DOI: 10.1016/J.Cardfail.2007.04.009  0.343
2007 Yin H, Chao J, Bader M, Chao L. Differential role of kinin B1 and B2 receptors in ischemia-induced apoptosis and ventricular remodeling. Peptides. 28: 1383-9. PMID 17644219 DOI: 10.1016/J.Peptides.2007.05.010  0.318
2007 Chao J, Li HJ, Yao YY, Shen B, Gao L, Bledsoe G, Chao L. Kinin infusion prevents renal inflammation, apoptosis, and fibrosis via inhibition of oxidative stress and mitogen-activated protein kinase activity. Hypertension. 49: 490-7. PMID 17224475 DOI: 10.1161/01.Hyp.0000255925.01707.Eb  0.775
2007 Yao YY, Yin H, Shen B, Chao L, Chao J. Tissue kallikrein infusion prevents cardiomyocyte apoptosis, inflammation and ventricular remodeling after myocardial infarction. Regulatory Peptides. 140: 12-20. PMID 17196272 DOI: 10.1016/J.Regpep.2006.11.020  0.381
2007 Li HJ, Yin H, Yao YY, Shen B, Bader M, Chao L, Chao J. Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation. Cardiovascular Research. 73: 130-42. PMID 17137568 DOI: 10.1016/J.Cardiores.2006.10.014  0.315
2006 Chao J, Bledsoe G, Yin H, Chao L. The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction. Biological Chemistry. 387: 665-75. PMID 16800727 DOI: 10.1515/Bc.2006.085  0.772
2006 Bledsoe G, Shen B, Yao Y, Zhang JJ, Chao L, Chao J. Reversal of renal fibrosis, inflammation, and glomerular hypertrophy by kallikrein gene delivery. Human Gene Therapy. 17: 545-55. PMID 16716111 DOI: 10.1089/Hum.2006.17.545  0.826
2006 Xia CF, Smith RS, Shen B, Yang ZR, Borlongan CV, Chao L, Chao J. Postischemic brain injury is exacerbated in mice lacking the kinin B2 receptor. Hypertension. 47: 752-61. PMID 16534002 DOI: 10.1161/01.Hyp.0000214867.35632.0E  0.326
2006 Xia CF, Yin H, Yao YY, Borlongan CV, Chao L, Chao J. Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis. Human Gene Therapy. 17: 206-19. PMID 16454654 DOI: 10.1089/Hum.2006.17.206  0.395
2006 Bledsoe G, Crickman S, Mao J, Xia CF, Murakami H, Chao L, Chao J. Kallikrein/kinin protects against gentamicin-induced nephrotoxicity by inhibition of inflammation and apoptosis. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 21: 624-33. PMID 16401625 DOI: 10.1093/Ndt/Gfi225  0.751
2006 Xia CF, Yin H, Borlongan CV, Chao J, Chao L. Postischemic infusion of adrenomedullin protects against ischemic stroke by inhibiting apoptosis and promoting angiogenesis. Experimental Neurology. 197: 521-30. PMID 16343485 DOI: 10.1016/J.Expneurol.2005.10.027  0.357
2005 Hua H, Zhou S, Liu Y, Wang Z, Wan C, Li H, Chen C, Li G, Zeng C, Chen L, Chao L, Chao J. Relationship between the regulatory region polymorphism of human tissue kallikrein gene and essential hypertension. Journal of Human Hypertension. 19: 715-21. PMID 15905889 DOI: 10.1038/sj.jhh.1001875  0.614
2005 Xia CF, Bledsoe G, Chao L, Chao J. Kallikrein gene transfer reduces renal fibrosis, hypertrophy, and proliferation in DOCA-salt hypertensive rats. American Journal of Physiology. Renal Physiology. 289: F622-31. PMID 15886273 DOI: 10.1152/Ajprenal.00427.2004  0.782
2005 Montanari D, Yin H, Dobrzynski E, Agata J, Yoshida H, Chao J, Chao L. Kallikrein gene delivery improves serum glucose and lipid profiles and cardiac function in streptozotocin-induced diabetic rats. Diabetes. 54: 1573-80. PMID 15855348 DOI: 10.2337/Diabetes.54.5.1573  0.369
2005 Smith RS, Agata J, Xia CF, Chao L, Chao J. Human endothelial nitric oxide synthase gene delivery protects against cardiac remodeling and reduces oxidative stress after myocardial infarction. Life Sciences. 76: 2457-71. PMID 15763077 DOI: 10.1016/J.Lfs.2004.11.028  0.422
2005 Chao JH, Sun YC, Chen CJ, Tseng CL, Yang MH. Determination of trace Al in silicon carbide by epithermal neutron activation. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 62: 561-7. PMID 15701410 DOI: 10.1016/j.apradiso.2004.09.007  0.56
2005 Chao J, Chao L. Kallikrein-kinin in stroke, cardiovascular and renal disease. Experimental Physiology. 90: 291-8. PMID 15653716 DOI: 10.1113/expphysiol.2004.028464  0.355
2005 Yin H, Chao L, Chao J. Kallikrein/kinin protects against myocardial apoptosis after ischemia/reperfusion via Akt-glycogen synthase kinase-3 and Akt-Bad.14-3-3 signaling pathways. The Journal of Biological Chemistry. 280: 8022-30. PMID 15611141 DOI: 10.1074/Jbc.M407179200  0.388
2004 Xia CF, Yin H, Borlongan CV, Chao J, Chao L. Adrenomedullin gene delivery protects against cerebral ischemic injury by promoting astrocyte migration and survival. Human Gene Therapy. 15: 1243-54. PMID 15684700 DOI: 10.1089/Hum.2004.15.1243  0.416
2004 Zhang JJ, Bledsoe G, Kato K, Chao L, Chao J. Tissue kallikrein attenuates salt-induced renal fibrosis by inhibition of oxidative stress. Kidney International. 66: 722-32. PMID 15253727 DOI: 10.1111/J.1523-1755.2004.00794.X  0.809
2004 Wang T, Li H, Zhao C, Chen C, Li J, Chao J, Chao L, Xiao X, Wang DW. Recombinant adeno-associated virus-mediated kallikrein gene therapy reduces hypertension and attenuates its cardiovascular injuries. Gene Therapy. 11: 1342-50. PMID 15175642 DOI: 10.1038/Sj.Gt.3302294  0.72
2004 Chao JC, Tseng HP, Chang CW, Chien YY, Au HK, Chen JR, Chen CF. Chicken extract affects colostrum protein compositions in lactating women. The Journal of Nutritional Biochemistry. 15: 37-44. PMID 14711459  0.585
2004 Xia CF, Yin H, Borlongan CV, Chao L, Chao J. Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis. Hypertension. 43: 452-9. PMID 14698996 DOI: 10.1161/01.Hyp.0000110905.29389.E5  0.424
2004 Yin H, Chao L, Chao J. Adrenomedullin protects against myocardial apoptosis after ischemia/reperfusion through activation of Akt-GSK signaling. Hypertension. 43: 109-16. PMID 14662648 DOI: 10.1161/01.Hyp.0000103696.60047.55  0.377
2003 Zhao C, Wang P, Xiao X, Chao J, Chao L, Wang DW, Zeldin DC. Gene therapy with human tissue kallikrein reduces hypertension and hyperinsulinemia in fructose-induced hypertensive rats. Hypertension. 42: 1026-33. PMID 14568997 DOI: 10.1161/01.Hyp.0000097603.55404.35  0.418
2003 Bledsoe G, Chao L, Chao J. Kallikrein gene delivery attenuates cardiac remodeling and promotes neovascularization in spontaneously hypertensive rats. American Journal of Physiology. Heart and Circulatory Physiology. 285: H1479-88. PMID 12816755 DOI: 10.1152/Ajpheart.01129.2002  0.768
2003 Miao RQ, Chen V, Chao L, Chao J. Structural elements of kallistatin required for inhibition of angiogenesis. American Journal of Physiology. Cell Physiology. 284: C1604-13. PMID 12734113 DOI: 10.1152/Ajpcell.00524.2002  0.721
2003 Agata J, Zhang JJ, Chao J, Chao L. Adrenomedullin gene delivery inhibits neointima formation in rat artery after balloon angioplasty. Regulatory Peptides. 112: 115-20. PMID 12667632 DOI: 10.1016/S0167-0115(03)00029-6  0.671
2003 Wang C, Chao J, Chao L. Adenovirus-mediated human prostasin gene delivery is linked to increased aldosterone production and hypertension in rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 284: R1031-6. PMID 12626364 DOI: 10.1152/Ajpregu.00660.2002  0.419
2003 Ni A, Yin H, Agata J, Yang Z, Chao L, Chao J. Overexpression of kinin B1 receptors induces hypertensive response to des-Arg9-bradykinin and susceptibility to inflammation. The Journal of Biological Chemistry. 278: 219-25. PMID 12411434 DOI: 10.1074/Jbc.M209490200  0.764
2002 Chao J, Chao L. The Role of Adrenomedullin in Cardiovascular and Renal Function. Drug News & Perspectives. 15: 511-518. PMID 12677190  0.344
2002 Dobrzynski E, Montanari D, Agata J, Zhu J, Chao J, Chao L. Adrenomedullin improves cardiac function and prevents renal damage in streptozotocin-induced diabetic rats. American Journal of Physiology. Endocrinology and Metabolism. 283: E1291-8. PMID 12424108 DOI: 10.1152/Ajpendo.00147.2002  0.404
2002 Agata J, Chao L, Chao J. Kallikrein gene delivery improves cardiac reserve and attenuates remodeling after myocardial infarction. Hypertension. 40: 653-9. PMID 12411458 DOI: 10.1161/01.Hyp.0000036035.41122.99  0.378
2002 Miao RQ, Agata J, Chao L, Chao J. Kallistatin is a new inhibitor of angiogenesis and tumor growth. Blood. 100: 3245-52. PMID 12384424 DOI: 10.1182/Blood-2002-01-0185  0.734
2002 Smith RS, Lin KF, Agata J, Chao L, Chao J. Human endothelial nitric oxide synthase gene delivery promotes angiogenesis in a rat model of hindlimb ischemia. Arteriosclerosis, Thrombosis, and Vascular Biology. 22: 1279-85. PMID 12171788 DOI: 10.1161/01.Atv.0000026613.18742.67  0.669
2002 Thongboonkerd V, Gozal E, Sachleben LR, Arthur JM, Pierce WM, Cai J, Chao J, Bader M, Pesquero JB, Gozal D, Klein JB. Proteomic analysis reveals alterations in the renal kallikrein pathway during hypoxia-induced hypertension. The Journal of Biological Chemistry. 277: 34708-16. PMID 12121987 DOI: 10.1074/Jbc.M203799200  0.429
2002 Chao J, Wang C, Chao L. Adenovirus-mediated gene transfer for cardiovascular and renal diseases. Methods in Enzymology. 346: 247-63. PMID 11883071 DOI: 10.1016/S0076-6879(02)46059-4  0.337
2002 Porcu P, Emanueli C, Kapatsoris M, Chao J, Chao L, Madeddu P. Reversal of angiogenic growth factor upregulation by revascularization of lower limb ischemia. Circulation. 105: 67-72. PMID 11772878 DOI: 10.1161/Hc0102.101360  0.331
2001 Chao J, Kato K, Zhang JJ, Dobrzynski E, Wang C, Agata J, Chao L. Human adrenomedullin gene delivery protects against cardiovascular remodeling and renal injury. Peptides. 22: 1731-7. PMID 11754958 DOI: 10.1016/S0196-9781(01)00510-1  0.698
2001 Wolf WC, Evans DM, Chao L, Chao J. A synthetic tissue kallikrein inhibitor suppresses cancer cell invasiveness. The American Journal of Pathology. 159: 1797-805. PMID 11696440 DOI: 10.1016/S0002-9440(10)63026-X  0.784
2001 Emanueli C, Salis MB, Stacca T, Gaspa L, Chao J, Chao L, Piana A, Madeddu P. Rescue of Impaired Angiogenesis in Spontaneously Hypertensive Rats by Intramuscular Human Tissue Kallikrein Gene Transfer Hypertension. 38: 136-141. PMID 11463774 DOI: 10.1161/01.Hyp.38.1.136  0.402
2001 Wang C, Dobrzynski E, Chao J, Chao L. Adrenomedullin gene delivery attenuates renal damage and cardiac hypertrophy in Goldblatt hypertensive rats American Journal of Physiology-Renal Physiology. 280. PMID 11352835 DOI: 10.1152/Ajprenal.2001.280.6.F964  0.455
2001 Chao J, Miao RQ, Chen V, Chen LM, Chao L. Novel roles of kallistatin, a specific tissue kallikrein inhibitor, in vascular remodeling. Biological Chemistry. 382: 15-21. PMID 11258665 DOI: 10.1515/Bc.2001.003  0.765
2001 Chen VC, Chao L, Pimenta DC, Bledsoe G, Juliano L, Chao J. Identification of a major heparin-binding site in kallistatin. The Journal of Biological Chemistry. 276: 1276-84. PMID 11016932 DOI: 10.1074/Jbc.M005791200  0.707
2000 Dobrzynski E, Wang C, Chao J, Chao L. Adrenomedullin gene delivery attenuates hypertension, cardiac remodeling, and renal injury in deoxycorticosterone acetate-salt hypertensive rats. Hypertension. 36: 995-1001. PMID 11116114 DOI: 10.1161/01.Hyp.36.6.995  0.467
2000 Chen VC, Chao L, Chao J. A positively charged loop on the surface of kallistatin functions to enhance tissue kallikrein inhibition by acting as a secondary binding site for kallikrein. Journal of Biological Chemistry. 275: 40371-40377. PMID 10991942 DOI: 10.1074/Jbc.M005691200  0.308
2000 Agata J, Miao RQ, Yayama K, Chao L, Chao J. Bradykinin B(1) receptor mediates inhibition of neointima formation in rat artery after balloon angioplasty. Hypertension. 36: 364-70. PMID 10988266 DOI: 10.1161/01.Hyp.36.3.364  0.731
2000 Zhang JJ, Yoshida H, Chao L, Chao J. Human adrenomedullin gene delivery protects against cardiac hypertrophy, fibrosis, and renal damage in hypertensive dahl salt-sensitive rats. Human Gene Therapy. 11: 1817-27. PMID 10986555 DOI: 10.1161/01.Hyp.36.Suppl_1.691-A  0.693
2000 Wolf WC, Yoshida H, Agata J, Chao L, Chao J. Human tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure. Kidney International. 58: 730-9. PMID 10916096 DOI: 10.1046/J.1523-1755.2000.00219.X  0.804
2000 Chen VC, Chao L, Chao J. Reactive-site specificity of human kallistatin toward tissue kallikrein probed by site-directed mutagenesis. Biochimica Et Biophysica Acta. 1479: 237-246. PMID 10862973 DOI: 10.1016/S0167-4838(00)00044-3  0.32
2000 Emanueli C, Salis MB, Chao J, Chao L, Agata J, Lin KF, Munaò A, Straino S, Minasi A, Capogrossi MC, Madeddu P. Adenovirus-mediated human tissue kallikrein gene delivery inhibits neointima formation induced by interruption of blood flow in mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 20: 1459-66. PMID 10845858 DOI: 10.1161/01.Atv.20.6.1459  0.647
2000 Wang D, Yoshida H, Song Q, Chao L, Chao J. Enhanced renal function in bradykinin B2 receptor transgenic mice American Journal of Physiology-Renal Physiology. 278. PMID 10710553 DOI: 10.1152/Ajprenal.2000.278.3.F484  0.358
2000 Miao RQ, Murakami H, Song Q, Chao L, Chao J. Kallistatin stimulates vascular smooth muscle cell proliferation and migration in vitro and neointima formation in balloon-injured rat artery. Circulation Research. 86: 418-24. PMID 10700446 DOI: 10.1161/01.Res.86.4.418  0.736
2000 Yoshida H, Zhang JJ, Chao L, Chao J. Kallikrein gene delivery attenuates myocardial infarction and apoptosis after myocardial ischemia and reperfusion. Hypertension. 35: 25-31. PMID 10642270 DOI: 10.1161/01.Hyp.35.1.25  0.65
2000 Wang C, Montanari D, Chao L, Chao J. Adenovirus-Mediated Human Kallikrein Gene Delivery Increases Endogenous Rat Tissue Kallikrein in Hypertensive Rat Models Hypertension. 36: 729-729. DOI: 10.1161/01.Hyp.36.Suppl_1.729-C  0.452
2000 Montanari D, Dobrzynski E, Chao J, Chao L. Human Tissue Kallikrein Gene Delivery Attenuates Cardiac Glycogen Accumulation in Streptozotocin-Induced Diabetic Rats Hypertension. 36: 703-703. DOI: 10.1161/01.Hyp.36.Suppl_1.703-C  0.366
2000 Madeddu PR, Salis BM, Chao J, Chao L, Costanza E. Human Tissue Kallikrein Gene Transfer Induces Angiogenesis Hypertension. 36: 691-691. DOI: 10.1161/01.Hyp.36.Suppl_1.691-B  0.361
2000 Emanueli C, Minasi A, Zacheo A, Chao J, Chao L, Salis BM, Madeddu PR, Capogrossi MC. Human Tissue Kallikrein Gene Transfer Accelerates Spontaneous Angiogenesis Response to Ischemia Hypertension. 36: 270-270. DOI: 10.1161/01.Hyp.36.Suppl_1.270-A  0.398
1999 Chao J, Wang C, Chao L. Gene therapy for hypertension: a review of potential targets. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. 11: 43-53. PMID 18031114 DOI: 10.2165/00063030-199911010-00005  0.34
1999 Murakami H, Miao RQ, Chao L, Chao J. Adenovirus-mediated kallikrein gene transfer inhibits neointima formation via increased production of nitric oxide in rat artery. Immunopharmacology. 44: 137-43. PMID 10604537 DOI: 10.1016/S0162-3109(99)00120-4  0.755
1999 Dobrzynski E, Yoshida H, Chao J, Chao L. Adenovirus-mediated kallikrein gene delivery attenuates hypertension and protects against renal injury in deoxycorticosterone-salt rats Immunopharmacology. 44: 57-65. PMID 10604525 DOI: 10.1016/S0162-3109(99)00121-6  0.449
1999 Madeddu P, Emanueli C, Gaspa L, Salis B, Milia AF, Chao L, Chao J. Role of the bradykinin B2 receptor in the maturation of blood pressure phenotype: lesson from transgenic and knockout mice. Immunopharmacology. 44: 9-13. PMID 10604518 DOI: 10.1016/S0162-3109(99)00105-8  0.328
1999 Zhang JJ, Wang C, Lin KF, Chao L, Chao J. Human tissue kallikrein attenuates hypertension and secretes into circulation and urine after intramuscular gene delivery in hypertensive rats. Clinical and Experimental Hypertension (New York, N.Y. : 1993). 21: 1145-60. PMID 10513833 DOI: 10.3109/10641969909052194  0.775
1999 Hatcher HC, Wright NM, Chao J, Chao L, Ma JX. Kallikrein-binding protein is induced by growth hormone in the dwarf rat. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 13: 1839-44. PMID 10506588 DOI: 10.1096/Fasebj.13.13.1839  0.374
1999 Zhang JJ, Chao L, Chao J. Adenovirus-mediated kallikrein gene delivery reduces aortic thickening and stroke-induced death rate in Dahl salt-sensitive rats. Stroke; a Journal of Cerebral Circulation. 30: 1925-31; discussion . PMID 10471446 DOI: 10.1161/01.Str.30.9.1925  0.612
1999 Murakami H, Yayama K, Miao RQ, Wang C, Chao L, Chao J. Kallikrein gene delivery inhibits vascular smooth muscle cell growth and neointima formation in the rat artery after balloon angioplasty. Hypertension. 34: 164-70. PMID 10454435 DOI: 10.1161/01.Hyp.34.2.164  0.763
1999 Murakami H, Yayama K, Chao J, Chao L. Atrial natriuretic peptide gene delivery attenuates gentamycin-induced nephrotoxicity in rats. Nephrology Dialysis Transplantation. 14: 1376-1384. PMID 10382996 DOI: 10.1093/Ndt/14.6.1376  0.439
1999 Emanueli C, Chao J, Regoli D, Chao L, Ni A, Madeddu P. The bradykinin B1 receptor and the central regulation of blood pressure in spontaneously hypertensive rats. British Journal of Pharmacology. 126: 1769-76. PMID 10372819 DOI: 10.1038/Sj.Bjp.0702527  0.744
1999 Jin L, Chao L, Chao J. Potassium supplement upregulates the expression of renal kallikrein and bradykinin B2 receptor in SHR American Journal of Physiology - Renal Physiology. 276. PMID 10070172 DOI: 10.1152/Ajprenal.1999.276.3.F476  0.416
1999 Lin KF, Chao J, Chao L. Atrial natriuretic peptide gene delivery reduces stroke-induced mortality rate in Dahl salt-sensitive rats. Hypertension. 33: 219-24. PMID 9931108 DOI: 10.1161/01.Hyp.33.1.219  0.678
1999 Wolf WC, Harley RA, Sluce D, Chao L, Chao J. Localization and expression of tissue kallikrein and kallistatin in human blood vessels. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 47: 221-8. PMID 9889257 DOI: 10.1177/002215549904700210  0.793
1998 Wolf WC, Harley RA, Sluce D, Chao L, Chao J. Cellular localization of kallistatin and tissue kallikrein in human pancreas and salivary glands. Histochemistry and Cell Biology. 110: 477-84. PMID 9826127 DOI: 10.1007/S004180050309  0.787
1998 Ni A, Chai KX, Chao L, Chao J. Molecular cloning and expression of rat bradykinin B1 receptor. Biochimica Et Biophysica Acta. 1442: 177-85. PMID 9804950 DOI: 10.1016/S0167-4781(98)00163-8  0.762
1998 Chao J, Zhang JJ, Lin KF, Chao L. Adenovirus-mediated kallikrein gene delivery reverses salt-induced renal injury in Dahl salt-sensitive rats. Kidney International. 54: 1250-60. PMID 9767541 DOI: 10.1046/J.1523-1755.1998.00104.X  0.759
1998 Stadnicki A, Chao J, Stadnicka I, Van Tol E, Lin KF, Li F, Sartor RB, Colman RW. Localization and secretion of tissue kallikrein in peptidoglycan-induced enterocolitis in Lewis rats. The American Journal of Physiology. 275: G854-61. PMID 9756518  0.639
1998 Lin KF, Chao J, Chao L. Atrial natriuretic peptide gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in salt-sensitive rats. Human Gene Therapy. 9: 1429-38. PMID 9681414 DOI: 10.1089/Hum.1998.9.10-1429  0.698
1998 Yayama K, Wang C, Chao L, Chao J. Kallikrein Gene Delivery Attenuates Hypertension and Cardiac Hypertrophy and Enhances Renal Function in Goldblatt Hypertensive Rats Hypertension. 31: 1104-1110. PMID 9576121 DOI: 10.1161/01.Hyp.31.5.1104  0.414
1998 Wang C, Chao C, Madeddu P, Chao L, Chao J. Central Delivery of Human Tissue Kallikrein Gene Reduces Blood Pressure in Hypertensive Rats Biochemical and Biophysical Research Communications. 244: 449-454. PMID 9514899 DOI: 10.1006/Bbrc.1998.8232  0.404
1998 Chao J, Zhang JJ, Lin KF, Chao L. Human kallikrein gene delivery attenuates hypertension, cardiac hypertrophy, and renal injury in Dahl salt-sensitive rats. Human Gene Therapy. 9: 21-31. PMID 9458239 DOI: 10.1089/Hum.1998.9.1-21  0.775
1998 Ni A, Chao L, Chao J. Transcription factor nuclear factor kappaB regulates the inducible expression of the human B1 receptor gene in inflammation. The Journal of Biological Chemistry. 273: 2784-91. PMID 9446586 DOI: 10.1074/Jbc.273.5.2784  0.747
1997 Wang C, Ford P, Chao C, Chao L, Chao J. Effect of cyclosporin A on the expression of tissue kallikrein, kininogen, and bradykinin receptor in rat. American Journal of Physiology. Renal Physiology. 273: F783-F789. PMID 29587107 DOI: 10.1152/Ajprenal.1997.273.5.F783  0.399
1997 Chao J, Jin L, Lin KF, Chao L. Adrenomedullin gene delivery reduces blood pressure in spontaneously hypertensive rats. Hypertension Research : Official Journal of the Japanese Society of Hypertension. 20: 269-77. PMID 9453262 DOI: 10.1291/Hypres.20.269  0.637
1997 Jin L, Zhang JJ, Chao L, Chao J. Gene therapy in hypertension: adenovirus-mediated kallikrein gene delivery in hypertensive rats. Human Gene Therapy. 8: 1753-61. PMID 9358025 DOI: 10.1089/Hum.1997.8.15-1753  0.675
1997 Chai KX, Chen VC, Ni A, Lindpaintner K, Rubattu S, Chao L, Chao J. Molecular cloning and expression of rat kallistatin gene. Biochimica Et Biophysica Acta. 1353: 277-86. PMID 9349723 DOI: 10.1016/S0167-4781(97)00100-0  0.763
1997 Lin KF, Chao L, Chao J. Prolonged reduction of high blood pressure with human nitric oxide synthase gene delivery. Hypertension. 30: 307-13. PMID 9314409 DOI: 10.1161/01.Hyp.30.3.307  0.645
1997 Chao J, Yang Z, Jin L, Lin KF, Chao L. Kallikrein gene therapy in newborn and adult hypertensive rats. Canadian Journal of Physiology and Pharmacology. 75: 750-6. PMID 9276159 DOI: 10.1139/Y97-086  0.662
1997 Wang C, Chao C, Chao L, Chao J. Expression of human tissue kallikrein in rat salivary glands and its secretion into circulation following adenovirus-mediated gene transfer Immunopharmacology. 36: 221-227. PMID 9228550 DOI: 10.1016/S0162-3109(97)00025-8  0.403
1997 Madeddu P, Varoni MV, Demontis MP, Chao J, Simson JA, Glorioso N, Anania V. Kallikrein-Kinin System and Blood Pressure Sensitivity to Salt Hypertension. 29: 471-477. PMID 9039144 DOI: 10.1161/01.Hyp.29.1.471  0.307
1997 Chao JR, Chen CS, Wang TF, Tseng LH, Tsai JJ, Kuo ML, Yen JJ, Yang Yen HF. Characterization of factor-independent variants derived from TF-1 hematopoietic progenitor cells: the role of the Raf/MAP kinase pathway in the anti-apoptotic effect of GM-CSF. Oncogene. 14: 721-8. PMID 9038380 DOI: 10.1038/sj.onc.1200884  0.613
1997 Ma JX, Song Q, Hatcher HC, Crouch RK, Chao L, Chao J. Expression and cellular localization of the kallikrein-kinin system in human ocular tissues. Experimental Eye Research. 63: 19-26. PMID 8983960 DOI: 10.1006/Exer.1996.0087  0.371
1996 Wang C, Chao C, Chen LM, Chao L, Chao J. High-salt diet upregulates kininogen and downregulates tissue kallikrein expression in Dahl-SS and SHR rats American Journal of Physiology-Renal Physiology. 271. PMID 8898012 DOI: 10.1152/Ajprenal.1996.271.4.F824  0.371
1996 Wang DZ, Song Q, Chen LM, Chao L, Chao J. Expression and cellular localization of tissue kallikrein-kinin system in human adrenal gland. American Journal of Physiology-Renal Physiology. 271. PMID 8853434 DOI: 10.1152/Ajprenal.1996.271.3.F709  0.348
1996 Chai KX, Ni A, Wang D, Ward DC, Chao J, Chao L. Genomic DNA sequence, expression, and chromosomal localization of the human B1 bradykinin receptor gene BDKRB1. Genomics. 31: 51-7. PMID 8808279 DOI: 10.1006/Geno.1996.0008  0.742
1996 Chao C, Madeddu P, Wang C, Liang Y, Chao L, Chao J. Differential regulation of kallikrein, kininogen, and kallikrein-binding protein in arterial hypertensive rats American Journal of Physiology-Renal Physiology. 271. PMID 8760246 DOI: 10.1152/Ajprenal.1996.271.1.F78  0.377
1996 Ma JX, Chao J, Chao L. Identification and characterization of two promoters of rat kallikrein-binding protein gene Biochimica Et Biophysica Acta. 1307: 285-293. PMID 8688463 DOI: 10.1016/0167-4781(96)81374-1  0.369
1995 Ma J, Yang Z, Chao J, Chao L. Intramuscular delivery of rat kallikrein-binding protein gene reverses hypotension in transgenic mice expressing human tissue kallikrein. Journal of Biological Chemistry. 270: 451-455. PMID 7814410 DOI: 10.1074/Jbc.270.1.451  0.377
1995 Chen LM, Richards GP, Chao L, Chao J. Molecular cloning, purification and in situ localization of human colon kallikrein. The Biochemical Journal. 307: 481-6. PMID 7733886 DOI: 10.1042/Bj3070481  0.358
1995 Chi KH, Chen CH, Chan WK, Chow KC, Chen SY, Yen SH, Chao JY, Chang CY, Chen KY. Effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients after cisplatin, fluorouracil, and leucovorin chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 13: 2620-8. PMID 7595716 DOI: 10.1200/JCO.1995.13.10.2620  0.581
1995 Wang C, Chao L, Chao J. Direct gene delivery of human tissue kallikrein reduces blood pressure in spontaneously hypertensive rats Journal of Clinical Investigation. 95: 1710-1716. PMID 7535795 DOI: 10.1172/Jci117847  0.426
1995 Lin KF, Chao J, Chao L. Human atrial natriuretic peptide gene delivery reduces blood pressure in hypertensive rats. Hypertension. 26: 847-53. PMID 7490138 DOI: 10.1161/01.Hyp.26.6.847  0.642
1994 Wang J, Xiong W, Yang Z, Davis T, Dewey MJ, Chao J, Chao L. Human tissue kallikrein induces hypotension in transgenic mice. Hypertension. 23: 236-43. PMID 7508423 DOI: 10.1161/01.Hyp.23.2.236  0.35
1992 Chagas JR, Hirata IY, Juliano MA, Xiong W, Wang C, Chao J, Juliano L, Prado ES. Substrate specificities of tissue kallikrein and T-kininogenase: their possible role in kininogen processing. Biochemistry. 31: 4969-74. PMID 1599922 DOI: 10.1021/Bi00136A008  0.313
1991 Wang J, Chao J, Chao L. Purification and characterization of recombinant tissue kallikrein from Escherichia coli and yeast Biochemical Journal. 276: 63-71. PMID 2039483 DOI: 10.1042/Bj2760063  0.332
1991 Madeddu P, Glorioso N, Maioli M, Demontis MP, Varoni MV, Anania V, Xiong W, Chai K, Chao J. Regulation of rat renal kallikrein expression by estrogen and progesterone. Journal of Hypertension. 9. DOI: 10.1097/00004872-199112000-00106  0.361
1990 Xiong W, Chen L, Woodley-Miller C, Simson JAV, Chao J. Identification, purification, and localization of tissue kallikrein in rat heart. Biochemical Journal. 267: 639-646. PMID 2140256 DOI: 10.1042/Bj2670639  0.344
Show low-probability matches.